The Impact of Change in Body Roundness Index on the Clinical Outcome of New Peritoneal Dialysis Patients
Open Access
- 1 January 2025
- journal article
- Published by S. Karger AG in Kidney Diseases
- Vol. 11 (1) , 674-683
Abstract
Introduction: Weight gain and central obesity are common in peritoneal dialysis (PD) patients. In the general population, body roundness index (BRI) has been found to be a convenient anthropometric measurement for the assessment of central obesity and visceral adiposity. However, the role of BRI in PD patients has not been explored. Methods: We recruited 145 new PD patients. BRI, body composition by bioimpedance spectroscopy, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) were measured at baseline and then after 1 year of PD. Patients were stratified into four groups based on their changes in BRI after 1 year of PD, using the traditional BRI cutoff of 5. Outcome measures include patient survival and hospitalization rate. Results: The change in BRI after 1 year of PD had a modest but significant correlation with the change in HOMA-IR (r = 0.497, p = 0.041). For the group with baseline BRI <5, patients who had their BRI raised to ≥5 (low-high group, n = 20) had significantly lower patient and technique survival rates than those whose BRI remained <5 (low-low group, n = 55), and the result remained significant after adjusting for clinical confounders by multi-variable Cox regression (adjusted hazard ratio 2.885, 95% CI: 1.278–6.509, p = 0.011). The low-high group also had significantly higher hospitalization rates (2.51 [1.63–3.93] vs. 0.98 [0.26–1.91] per year, p = 0.0008) and longer hospitalization stay (17.3 [12.2–35.5] vs. 5.0 [1.0–13.3] days per year, p = 0.015) than the low-low group. Conclusion: An increase in BRI after 1 year of PD was associated with worsening of insulin resistance, worse patient survival, and more hospitalization.Keywords
This publication has 26 references indexed in Scilit:
- Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patientsClinical Chemistry and Laboratory Medicine (CCLM), 2017
- Metabolic Syndrome in Peritoneal Dialysis PatientsClinical Journal of the American Society of Nephrology, 2014
- Body Fat Distribution and Insulin ResistanceNutrients, 2013
- Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopyInternational Urology and Nephrology, 2012
- Inflammation in Peritoneal DialysisNephron Clinical Practice, 2010
- Body fluid volume determination via body composition spectroscopy in health and diseasePhysiological Measurement, 2006
- Oral Sodium Bicarbonate for the Treatment of Metabolic Acidosis in Peritoneal Dialysis PatientsJournal of the American Society of Nephrology, 2003
- Malnutrition, Inflammation, and Atherosclerosis in Peritoneal Dialysis PatientsPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2001
- Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance testDiabetologia, 2000
- Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis.Journal of the American Society of Nephrology, 1996